[SUMMARY]Cagrilintide is a long-acting synthetic amylin analogue used in combination with semaglutide (marketed as CagriSema) for treating obesity and overweight with related conditions. It works by increasing satiety and influencing appetite regulation through direct effects on the brain. CagriSema has shown significant weight reduction in clinical trials, with benefits including improved blood pressure and metabolic markers. Research Only.